China Nuokang Bio-Pharmaceutical Inc. (Nasdaq: NKBP) announced that Robert Tianruo Pu, the chief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE